Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$18.1 million.

  • Medifast's Income towards Parent Company fell 237289.84% to -$18.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$18.7 million, marking a year-over-year decrease of 100591.95%. This contributed to the annual value of -$18.7 million for FY2025, which is 99468.14% down from last year.
  • As of Q4 2025, Medifast's Income towards Parent Company stood at -$18.1 million, which was down 237289.84% from -$2.3 million recorded in Q3 2025.
  • Medifast's 5-year Income towards Parent Company high stood at $47.0 million for Q2 2021, and its period low was -$18.1 million during Q4 2025.
  • Its 5-year average for Income towards Parent Company is $19.5 million, with a median of $24.8 million in 2022.
  • Within the past 5 years, the most significant YoY rise in Medifast's Income towards Parent Company was 13036.81% (2025), while the steepest drop was 237289.84% (2025).
  • Over the past 5 years, Medifast's Income towards Parent Company (Quarter) stood at $34.0 million in 2021, then fell by 22.06% to $26.5 million in 2022, then crashed by 77.24% to $6.0 million in 2023, then crashed by 86.79% to $797000.0 in 2024, then crashed by 2372.9% to -$18.1 million in 2025.
  • Its last three reported values are -$18.1 million in Q4 2025, -$2.3 million for Q3 2025, and $2.5 million during Q2 2025.